Facilitating equitable prevention and management of gout for Maori in Northland, New Zealand, through a collaborative primary care approach

被引:18
|
作者
Lawrence, Aniva [1 ,2 ]
Scott, Sharon [1 ,2 ]
Saparelli, Fabio [3 ]
Greville, Georgina [4 ]
Miller, Andrew [5 ]
Taylor, Andrea [6 ]
Gow, Peter [7 ]
机构
[1] Manaia Primary Hlth Org, POB 1878, Whangarei 0140, New Zealand
[2] Te Tai Tokerau Primary Hlth Org, POB 1878, Whangarei 0140, New Zealand
[3] Univ Auckland, Sch Med, Private Bag 92019, Auckland 1142, New Zealand
[4] Middlemore Hosp, Dept Rheumatol, Private Bag 93311, Auckland 1640, New Zealand
[5] Bush Rd Med Ctr, POB 4320, Kamo 0112, Whangarei, New Zealand
[6] Northland Dist Hlth Board, Private Bag 9742, Whangarei 0148, New Zealand
[7] Counties Manukau Dist Hlth Board, Private Bag 94052, South Auckland Mail Cent 2240, New Zealand
关键词
Gout; medications; blood testing; primary health care; Maori health services; Pacific communities;
D O I
10.1071/HC18082
中图分类号
R1 [预防医学、卫生学];
学科分类号
1004 ; 120402 ;
摘要
INTRODUCTIONThe Gout Stop Programme was developed for primary care in Northland, New Zealand, to address inequitable health outcomes for Maori and Pacific people with gout. AIMThe aim of the programme was to make it easier for clinicians to prescribe urate-lowering treatment, facilitate patient adherence through education and support, and reduce barriers to gout prevention and long-term management. METHODSFrom 2015 to 2017, patients with acute gout who met inclusion criteria were prescribed treatment according to a Gout Stop Pack' option, based on renal function and diabetes status. Patients were monitored by community pharmacists. Gout educators and a Gout Kaiawhina (community support worker) provided education and support to patients and whanau (families). Patient completion of the programme and outcomes, according to target serum urate level, were recorded. Patient experience was documented using a questionnaire and rating scale. RESULTSIn total, 160 clinicians prescribed therapy at 887 patient presentations; 71% were Maori and Pacific patients. The completion rate was 55% in this group and 84% for the non-Maori and non-Pacific group. In the Maori and Pacific group, 40% reached the target serum urate level (<= 0.36 mmol L-1) in 91 days, and 26% required further titration. In the non-Maori/non-Pacific group, these rates were 51% and 19% respectively. Following programme completion, 68% of Maori and Pacific patients and 65% of non-Maori and non-Pacific patients continued to take allopurinol. The 21 patients interviewed rated the programme as excellent or very good. DISCUSSIONCulturally appropriate education and support for patients and the primary care team was essential. Collaboration between prescribers, community pharmacists and support workers reduced barriers to initiating prevention and long-term urate-lowering treatment and urate testing in this high-needs gout population.
引用
收藏
页码:117 / 127
页数:11
相关论文
共 50 条
  • [1] A repeat audit of primary care management of group A streptococcal pharyngitis in Northland, New Zealand 2016
    Shetty, Anil
    Mills, Clair
    Eggleton, Kyle
    JOURNAL OF PRIMARY HEALTH CARE, 2018, 10 (01) : 18 - 24
  • [2] Management of gout: Primary care approach
    Omole, O. B.
    Ogunbanjo, G. A.
    SOUTH AFRICAN FAMILY PRACTICE, 2009, 51 (06) : 471 - 474
  • [3] Primary care management of Type 2 diabetes in the New Zealand Maori population.
    Simmons, JL
    Mahendran, D
    Cross, S
    Kumar, S
    DIABETOLOGIA, 2003, 46 : A440 - A441
  • [4] A Maori approach to management: Contrasting traditional and modern Maori management practices in Aotearoa New Zealand
    Mika, Jason Paul
    O'Sullivan, John Gerard
    JOURNAL OF MANAGEMENT & ORGANIZATION, 2014, 20 (05) : 648 - 670
  • [5] Societal and Cultural Attitudes to Gout: An Important Consideration in the Successful Management of Gout among Maori in Aotearoa New Zealand
    Gow, Peter J.
    Gow, Virginia F.
    Waldon, John
    CURRENT RHEUMATOLOGY REVIEWS, 2011, 7 (02) : 170 - 180
  • [6] Gout management in primary care approach; Literature Review
    Alghamdi, Abdullah Abdulhameed
    Mutlaqah, Mohammed Abdullah
    Labani, Amal Mohammed H.
    Alahmadi, Lujain Mohsen A.
    Alahmari, Abdulaziz Fayez
    Albalawi, Rahaf Abdulrahman
    Alsalim, Batool Saad
    Alghamdi, Ibrahim Abdulhamid
    Alenezi, Ibtihaj Qaseem M.
    Alotaibi, Abdullah Hathal
    Aljouid, Futoon Abdullah
    INTERNATIONAL JOURNAL OF PHARMACEUTICAL RESEARCH AND ALLIED SCIENCES, 2021, 10 (01): : 19 - 23
  • [7] Anticoagulation management by community pharmacists in New Zealand: an evaluation of a collaborative model in primary care
    Harrison, Jeff
    Shaw, John P.
    Harrison, Jenny E.
    INTERNATIONAL JOURNAL OF PHARMACY PRACTICE, 2015, 23 (03) : 173 - 181
  • [8] Childhood immunisations in Northland, New Zealand: declining care and the journey through the immunisation pathway
    Rumball-Smith, Juliet
    Kenealy, Timothy
    NEW ZEALAND MEDICAL JOURNAL, 2016, 129 (1438) : 15 - 21
  • [9] Approach to collaborative glaucoma care in New Zealand: An update
    Botha, Verona E.
    Taylor, Siok-Khim
    Benefield, Jacob
    Ah-Chan, John
    CLINICAL AND EXPERIMENTAL OPHTHALMOLOGY, 2019, 47 (06): : 798 - 799
  • [10] A collaborative approach to wildlife disease management in New Zealand
    Jakob-Hoff, Richard
    AVIAN BIOLOGY RESEARCH, 2008, 1 (01) : 32 - 33